Effects of long-term treatment with human pure follicle-stimulating hormone on semen parameters and sperm-cell ultrastructure in idiopathic oligoteratoasthenozoospermia

被引:16
作者
Arnaldi, G
Balercia, G
Barbatelli, G
Mantero, F
机构
[1] Univ Ancona, Inst Internal Med, Div Endocrinol, I-60128 Ancona, Italy
[2] Univ Ancona, Electron Microscopy Unit, Inst Normal Human Morphol, I-60128 Ancona, Italy
关键词
follicle-stimulating hormone; idiopathic oligoteratoasthenozoospermia; male infertility; semen;
D O I
10.1046/j.1439-0272.2000.00358.x
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Ten subfertile men affected by idiopathic oligoteratoas- thenozoospermia and exhibiting normal serum hormone levels received a long-term treatment with human pure follicle-stimulating hormone (hp-FSH) (150 IU, intramuscularly, three times per week for 6 months). Semen parameters and ultrastructural features of spermatozoa were evaluated before and after therapy. The results showed an increase in sperm cell concentration and, more interestingly, motility. Electron microscopic examination revealed an improved fine architectural pattern, mainly involving acrosome, head and chromatin and middlepiece, in accordance with the positive changes of functional data. No significant changes of hp-FSH treatment on serum hormone levels were observed, since the latter were found to be substantially unchanged after 6 months of therapy. The present data suggest: (i) the benefit of hp-FSH administration in idiopathic oligoteratoasthenozoospermia, when hormone parameters support a substantial integrity of spermatogenetic microenvironment and (ii) an optimal effect after longterm (6 months) therapy.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 34 条
[21]  
JOCKENHOVEL F, 1990, CLIN ENDOCRINOL, V33, P573
[22]  
KULA K, 1991, ANDROLOGIA, V23, P127
[23]  
LIPITZ S, 1992, ANDROLOGIA, V24, P261
[24]  
MARGALIOTH EJ, 1983, FERTIL STERIL, V39, P841
[25]  
MASHIACH R, 1992, FERTIL STERIL, V57, P1052
[26]  
MUNDY AJ, 1994, FERTIL STERIL, V61, P751
[27]   CARE FOR THE INFERTILE MALE [J].
NIESCHLAG, E .
CLINICAL ENDOCRINOLOGY, 1993, 38 (02) :123-133
[28]  
PUSCH HH, 1986, ANDROLOGIA, V18, P201
[29]  
Schill WB, 1995, INT J ANDROL, V18, P56
[30]  
Sharpe Richard M., 1994, P1363